Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF – Get Free Report) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 900 shares, a growth of ∞ from the May 14th total of 0 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.
Jacobio Pharmaceuticals Group Price Performance
JBPHF stock opened at $0.87 on Tuesday. Jacobio Pharmaceuticals Group has a 12-month low of $0.73 and a 12-month high of $1.10. The stock’s 50 day simple moving average is $0.87 and its 200 day simple moving average is $0.86.
About Jacobio Pharmaceuticals Group
Jacobio Pharmaceuticals Group Co, Ltd. is a clinical‐stage biopharmaceutical company headquartered in Tianjin, China, specializing in the discovery and development of small‐molecule therapeutics for oncology. The company’s research platform is built around targeted kinase inhibitors and epigenetic modulators aimed at addressing acute leukemias and select solid tumors with high unmet medical need.
Jacobio’s pipeline comprises multiple preclinical and clinical‐stage programs focused on genetically defined cancers, including agents designed to inhibit mutant FLT3, menin‐MLL interactions and other oncogenic drivers.
See Also
- Five stocks we like better than Jacobio Pharmaceuticals Group
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Jacobio Pharmaceuticals Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jacobio Pharmaceuticals Group and related companies with MarketBeat.com's FREE daily email newsletter.
